Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
American Oncology Network Inc (AONCW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/31/2025: AONCW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -29.67% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/31/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 13861 | Beta 0.52 | 52 Weeks Range 0.00 - 0.39 | Updated Date 04/1/2025 |
52 Weeks Range 0.00 - 0.39 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.23% | Operating Margin (TTM) 1.7% |
Management Effectiveness
Return on Assets (TTM) -2.38% | Return on Equity (TTM) -30.17% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 23133012 |
Shares Outstanding - | Shares Floating 23133012 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
American Oncology Network Inc
Company Overview
History and Background
American Oncology Network (AON) was founded in 2018. It is a physician-led, community-based oncology network focused on expanding access to cancer care in communities across the United States. AON partners with independent practices, providing resources and infrastructure to enhance patient care and practice management.
Core Business Areas
- Community Oncology Network: AON partners with community-based oncology practices, providing them with resources, technology, and support services to improve patient care and practice efficiency.
- Pharmacy and Laboratory Services: AON offers centralized pharmacy and laboratory services to its partner practices, aiming to reduce costs and improve quality.
- Care Management: AON provides care management programs to help patients navigate their cancer journey, improve outcomes, and reduce costs.
Leadership and Structure
AON is led by a management team with experience in healthcare administration, oncology, and business development. The organizational structure consists of corporate leadership, regional directors, and support staff working with partner practices.
Top Products and Market Share
Key Offerings
- Practice Management Services: AON provides comprehensive practice management services to affiliated oncology practices. Includes billing, IT, HR, and compliance support. Competitors include McKesson, Cardinal Health, and AmerisourceBergen. Limited market share data available for specific practice management services within oncology networks.
- Centralized Pharmacy and Lab Services: AON offers centralized pharmacy and lab services to partner practices to improve efficiency and reduce costs. The exact market share is difficult to determine. Competitors include large pharmaceutical distributors and lab companies like Quest Diagnostics and Labcorp.
- Care Management Programs: AON implements care management programs to support patients throughout their cancer treatment. Competitors include cancer centers, hospitals, and independent care management companies. Market share data is limited and fragmented.
Market Dynamics
Industry Overview
The oncology market is large and growing, driven by an aging population, increasing cancer incidence, and advances in treatment options. Community oncology practices play a vital role in delivering cancer care, but face increasing challenges related to reimbursement, regulatory compliance, and competition from larger healthcare systems.
Positioning
AON positions itself as a partner to community oncology practices, offering resources and support to help them thrive in a challenging environment. Its competitive advantage lies in its physician-led model, comprehensive service offerings, and focus on improving patient care.
Total Addressable Market (TAM)
The total addressable market for oncology services in the US is estimated to be hundreds of billions of dollars annually. AON's position relative to this TAM is focused on capturing a segment of the market share through its network of community oncology practices.
Upturn SWOT Analysis
Strengths
- Physician-led model
- Comprehensive service offerings
- Focus on community oncology
- Strong growth trajectory
- Experienced management team
Weaknesses
- Limited brand recognition
- Dependence on partner practices
- Potential for conflicts of interest with partner physicians
- Smaller scale compared to larger competitors
- Geographic concentration
Opportunities
- Expanding network of partner practices
- Developing new service offerings
- Leveraging technology to improve patient care
- Capitalizing on the shift towards value-based care
- Acquiring smaller oncology practices
Threats
- Increasing competition from larger healthcare systems
- Changes in reimbursement policies
- Regulatory scrutiny
- Economic downturn
- Consolidation in the oncology market
Competitors and Market Share
Key Competitors
- McKesson (MCK)
- Cardinal Health (CAH)
- AmerisourceBergen (COR)
- The US Oncology Network (part of McKesson)
Competitive Landscape
AON's advantage is its community-focused, physician-led model. Disadvantages include smaller scale and limited brand recognition compared to larger competitors like McKesson and Cardinal Health.
Major Acquisitions
Preferred Oncology Management
- Year: 2023
- Acquisition Price (USD millions):
- Strategic Rationale: Expanded AON's presence and service offerings in key markets. AON is expanding its geographic footprint and strengthening its service capabilities.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been substantial, primarily driven by the expansion of its network through partnerships with community oncology practices.
Future Projections: Future projections suggest continued growth, driven by increasing cancer incidence and the ongoing demand for community-based oncology services. However, specific projections are not available due to its private status.
Recent Initiatives: Recent strategic initiatives include expanding its network of partner practices, implementing new care management programs, and investing in technology to improve patient care.
Summary
American Oncology Network is a growing community oncology network. Its physician-led model and comprehensive service offerings are working well for them. The company needs to be aware of the competition from larger healthcare systems and the changes in reimbursement policies that could impact their business.
Similar Companies
CAH
Cardinal Health Inc
CAH
Cardinal Health Inc
COR
Cencora Inc.
COR
Cencora Inc.
MCK
McKesson Corporation
MCK
McKesson Corporation
Sources and Disclaimers
Data Sources:
- American Oncology Network Inc. Website
- Company Press Releases
- Third-party industry reports
- Competitor Websites
Disclaimers:
This analysis is based on publicly available information and may not reflect the most current or complete data. Financial information is limited due to the company's private status. Market share estimates are approximate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Oncology Network Inc
Exchange NASDAQ | Headquaters Fort Myers, FL, United States | ||
IPO Launch date 2021-05-13 | CEO & Director Mr. Todd Schonherz | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1914 | Website https://www.aoncology.com |
Full time employees 1914 | Website https://www.aoncology.com | ||
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.